Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients
J
Jonathan L. Berkowitz, MD, PhD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
2758 participants needed
1 Location
Brief description of study
The tissues/specimens will be evaluated for the identification of novel biomarkers, novel DNA/RNA alterations, as well as other disease-specific cellular alterations as one of the early steps to identify potential therapeutic and diagnostic targets. If novel targets are identified, more in depth studies under this protocol may be performed to determine the potential clinical impact of these cellular alterations.
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: diagnostic and therapeutic biomarkers
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
Exclusion Criteria:
Updated on
01 Aug 2024.
Study ID: 1943658; BALL-MTG-022
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
